NT-proBNP Measurements to Rule-out Heart Failure Among Patients With Atrial Fibrillation: A Prospective Clinical Study

Author(s):  
EP Europace ◽  
2017 ◽  
Vol 19 (suppl_1) ◽  
pp. i49-i49
Author(s):  
D Mercea ◽  
R Ianos ◽  
D Leucuta ◽  
C Pop ◽  
A Cozma ◽  
...  

Author(s):  
S. B. Amarnath ◽  
K. Purushotham

<p class="abstract"><strong>Background:</strong> Hoarseness of voice is one of the widely found symptom in otolaryngological practice and is invariably the earlier manifestation of laryngeal involvement directly or deviously. The disease ranges from utterly benign to the most malignant and therefore a varying degree of connotation is attached to this. Present study is conducted to know the incidence, aetiopathological factors causing hoarseness of voice and its management.</p><p class="abstract"><strong>Methods:</strong> Present study is a prospective clinical study conducted in SVRRG Hospital, Tirupati from October 2008 to 2010 in all patients of both sexes with hoarseness of voice for more than 3 weeks duration were included. Hoarseness of voice due to congenital diseases, nose and nasopharyngeal pathology, oral and oropharyngeal pathology, CNS lesions were excluded from the study. All patients were subjected to detailed history, complete ENT examination, laryngoscopic examination, micro laryngeal excision or biopsy was taken to arrive the diagnosis and management was done accordingly.  </p><p class="abstract"><strong>Results:</strong> Incidence of hoarseness of voice was 0.38% noted in our study. Most common age group affected are 4<sup>th</sup> to 6<sup>th</sup> decade with male to female ratio 2.5:1. Malignancy is the commonest cause, smoking and alcohol consumption were major etiological factors.</p><p class="abstract"><strong>Conclusions:</strong> In middle aged and elderly persons with hoarseness of voice more than 3 weeks duration should not be ignored and to be investigated further to rule out malignancy.</p>


2000 ◽  
Vol 36 (2) ◽  
pp. 125-132 ◽  
Author(s):  
AC Vollmar

The prevalence of cardiomyopathy in Irish wolfhounds was evaluated by retrospective review of the results of cardiovascular examinations carried out in 500 dogs presented for veterinary services at the author's practice. Abnormalities were found in 209 (41.8%) of the dogs examined. Dilated cardiomyopathy (DCM) was diagnosed in 121 (24.2%) of the dogs and was accompanied by atrial fibrillation in 106 dogs. Seventeen dogs were suffering from advanced congestive heart failure (CHF), and 55 dogs were suffering from mild to moderate CHF as a result of DCM. Congestive heart failure was most commonly characterized by mild to severe pleural effusion due to right-sided heart failure in addition to pulmonary edema. Rhythm disturbances without evidence of DCM were detected in 48 dogs. Forty dogs had echocardiographic abnormalities without signs of DCM. Soft to moderate mitral regurgitations were diagnosed in 13 (2.6%) of these 40 dogs examined. In 39 dogs that died as a result of DCM, the median survival time from the time of diagnosis was 5.1 months, and in 59 dogs with DCM that are still alive, the median survival time is 15.7 months.


2020 ◽  
Vol 7 (3) ◽  
pp. 942-952
Author(s):  
Djawid Hashemi ◽  
Moritz Blum ◽  
Meinhard Mende ◽  
Stefan Störk ◽  
Christiane E. Angermann ◽  
...  

2003 ◽  
Vol 2 (1) ◽  
pp. 131
Author(s):  
A ZAPHIRIOU ◽  
S ROBB ◽  
G MENDEZ ◽  
T MURRAYTHOMAS ◽  
S HARDMAN ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document